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Abstract 
Background: Recently, a continuous growth of interest has been observed in antimicrobial peptides (AMPs) in the 
light of an alarming increase in resistance of bacteria and fungi against antibiotics. AMPs are used as biomarkers 
in diagnosis and monitoring of oral cavity pathologies. Therefore, the determination of specific protein profiles in 
children diagnosed with early childhood caries (ECC) might be a basis for effective screening tests and specialized 
examinations which may enable progression of disease.
Methods: The objective of the studies was to determine the role of histatin-5 and β-defensing-2 as a diagnostic 
marker of early childhood caries progression. In this work, results of concentration determination of two salivary 
proteins (histatin-5 and β-defensin-2) were presented. In addition, bacterial profiles from dental plaque in various 
stages of ECC and control were marked. The assessment of alteration in the concentration of these two proteins in a 
study group of children with various stages of ECC and a control group consisting of children with no symptoms was 
performed by enzyme-linked immunosorbent assays.
Results: The statistical analysis showed a significant increase in the concentration of histatin-5 and β-defensin-2 in 
the study group compared to the control group and correlated with the progression of the disease.
Conclusions: The confirmation of concentration changes in these proteins during the progression of dental caries 
may discover valuable disease progression biomarkers.
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Background
Interest for saliva as a study material is a consequence of 
the search for body fluid obtaining of which is easy, non-
invasive, and relatively inexpensive [1, 2]. It is also possible 
to determine salivary proteins occurring in small concen-
trations. Salivary peptides have been used in monitoring 
pathological conditions such as oral cavity, larynx and 
breast cancers [3], systemic sclerosis, Sjögren’s syndrome, 
cirrhosis, and mucoviscidosis [4]. Currently, saliva analy-
sis is also used in detecting infectious diseases [5].
Histatins (HST) and defensins are antibacterial pro-
teins of the oral cavity, and their biological activity is 
directed toward the protection against infectious dis-
eases, including dental caries. The development of caries 
is a consequence of imbalance of a natural equilibrium 
ensured by inborn defense systems. Periodical physiolog-
ical changes of concentrations of the mentioned proteins 
aim at restoring ecological balance in the oral cavity.
It seems that these proteins may be involved in pre-
venting numerous diseases such as dental caries, and 
because these proteins naturally occur in the oral cavity 
they should be clinically well tolerated.
Defensins
The role of defensins is still not yet entirely under-
stood. Saliva contains both α-defensins and β-defensins. 
Alpha-defensins (HNP-1,2,3) are secreted by neutro-
phils, whereas β-defensins (HBD-1,2) undergo a specific 
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expression in salivary duct cells, not in salivary gland ves-
icles. The increase of the number of neutrophils in blood 
affects an increase in α-defensin concentration in saliva 
[6]. A temporary, increased level of α-defensins is related 
to, i.e. acute inflammation, fever, poisoning, hemorrhage, 
quickly developing malignant tumor [7].
They have local effect—protect salivary glands against 
bacterial invasion (Gram-negative: P. aeruginosa, E. coli; 
Gram-positive: S. aureus, S. pneumoniae, S. faecalis), 
viruses (HIV-1, HSV-1, HAdV), and fungi (C. albicans).
β-Defensins in  vitro exhibit cytotoxic activity against 
different eukaryotic and tumor cells [8–10]. In physi-
ologic in vitro concentrations, HBD stimulate the prolif-
eration of these cells, while in higher concentrations they 
are cytotoxic to them [11]. β-Defensins also participate in 
specific immune response as chemotactic factors—they 
adhere to CCR6 chemokine receptor on dendritic cells 
[12].
The expression of β-defensin-2 (HBD-2) is induced 
by proinflammatory cytokines (IL-1β, IFN-γ, TNF-
α) in complex signaling pathway [13–15] activated by 
the effect of LPS lipopolysaccharide on epithelial cells 
depending on mitogen-activated protein kinases (MAPK) 
(Fig. 1) [15].
Histatins
Histatins (HST)—produced in parotid and sublingual sal-
ivary glands—are among the main natural antimicrobial 
proteins of saliva. Among the 12 main forms of proteins 
occurring in saliva are HST-1, -3 and -5. HST-1 and -3 
are the products of different genes, and HST-2 is formed 
as an effect of post-translational HST-1 modification. 
The remaining types are formed from HST-3 transitions 
or HST-5 and -6 degradation. HST-1, -3, and -5 consti-
tute 85 % of the total content of these proteins in saliva, 
and HST-3 and -5 have the strongest antimicrobial activ-
ity. HST-1, -3, and -5 also constitute components of the 
acquired enamel pellicle (AEP).
HST destabilize cellular membrane of bacteria by 
assimilating with its surface leading to cell damage. 
Moreover, HST decrease outflow of proinflammatory 
cytokines (interleukins, TNFα, metabolites of arachi-
donic and other acids) as a response of organism to 
stimulation of cell walls of Gram-negative bacteria with 
lipopolysaccharide [16]. A range of antibacterial effect 
includes microbes such as S. mutans, S. aureus, P. gingi-
valis, E. coli, and others [17, 18].
HST-5 was demonstrated as the only protein from the 
HST group exhibiting antiviral activity (against HIV-1—
inhibition of replication by the active domain of HST-5—
Dh-5) [19, 20] (Fig. 2).
Among other HST functions known is their activ-
ity as inhibitors of proteolytic enzymes originating 
from microbes (metalloproteases, trypsin-like enzymes, 
cysteine proteases) or host (collagenases) [18, 21]. Espe-
cially important is the inhibition of collagenases (MMP) 
activity of which increases under pathological conditions 
and is related to inflammatory and degenerative diseases 
and carcinogenic processes. Currently, HST are con-
sidered to be one of the dominant substances of saliva 
participating in wound healing [22]. HST acting syner-
gistically with epidermal growth factor (EGF) activate G 
protein-coupled receptors, which in consequence lead to 
growth and migration of cells (Fig. 2) [23].
The objective of this study was an attempt to use 
the determination of salivary proteins: HST-5 and 
β-defensin-2 as markers of dental caries progression at 
various stages of its development.
Methods
Subject of the study
The study was conducted between 2010 and 2013 and 
included 82 pediatric patients from the Department of 
Pediatric Dentistry, Institute of Dentistry, Jagiellonian 
University, Medical College in Krakow, Lesser Poland 
Małopolska province. The study included strains iso-
lated from patients (n  =  41; average age  =  5  ±  2.3) 
diagnosed with ECC in deciduous teeth. Patients were 
divided in two groups: the mild group (1–2 in ICDAS II 
codes; n = 17) with the initial demineralization involve-
ment (white spots/non-cavitated lesion) and severe 
group (with cavitated lesion) which was considered to be 
≥3 in ICDAS II codes (n =  24). The control group was 
formed of strains isolated from children (n =  41; aver-
age age =  5 ±  1.5) without caries lesions in deciduous 
teeth, who were kept under the clinic’s control (Table 1). 
In a clinical evaluation of the patients, the presence of 
tooth decay in deciduous and permanent teeth, num-
ber of teeth removed due to caries, and filled teeth were 
assessed. The study describing the indexes of caries, dmf/
DMF and the frequency, was conducted in accordance 
with the criteria established by the World Health Organi-
zation (1997) for epidemiological studies (Oral Health 
Surveys Basic Data) in artificial lighting using a dental 
mirror and probe.
The classification of patients for the study was per-
formed during a routine dental examination. This exami-
nation was conducted by a qualified dentist (internal 
examiner), with many years of experience in epidemio-
logical studies of the oral cavity. Kappa coefficient was set 
at 0.91 in the pilot studies, which indicates the internal 
examiner’s reliability. The legal guardians of the partici-
pants of the study were fully informed about its aim and 
course and agreed on their children’s participation. The 
factors excluding from participation in the study were 
insufficiently developed chewing activity observed in 
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small children and mentally disabled patients, and the 
lack of an agreement from legal guardians for their chil-
dren’s participation in the experiment.
Material collection
Saliva and plaque samples were obtained from chil-
dren with caries and also from children with no car-
ies symptoms. After the classification of the patients for 
the research, scrapings from carious foci (in the case of 
children with caries) or from dental plaque (in children 
without caries) were collected for the examination using 
an open system composed of a sterile cotton swab placed 
in a test tube. Unstimulated saliva samples (2  ml) were 
collected into sterile plastic tubes in the morning before 
tooth-brushing and any clinical examination. Saliva sam-
ples were homogenized and clarified by centrifugation 
at 10,000×g for 15 min at 4  °C. The aliquots of clarified 
supernatants were kept at −70  °C until needed for the 
measurements.
The patients maintained a fasting status, and sampling 
was performed between 8 and 10 am after the prior oral 
cavity rinsing with distilled water. The collected material 
was sealed in sterile test tubes, inhibiting oxygen access, 
and transported at room temperature to the laboratory 
within a time period of no longer than 1 h. Saliva sam-
ples were centrifuged at 1500×g for 10  min; superna-
tants were collected and stored at −20 °C. Then, salivary 
β-defensin-2 and HST-5 levels were measured by ELISA 
(BIO-RAD, Hercules, CA, USA).
Bacterial culture of collected material on HLR‑S medium
The material was inoculated on a selective medium 
(HLR-S) in the laboratory. The range of inhibition of 
the growth of bacteria colonizing an oral cavity was 
Fig. 1 Signaling pathways in inducible expression of HBD-2 in epithelial cell. (ERK extracellular-signal-regulated kinase, hBD-2 human β-defensin-2, 
IκBα nuclear factor of κ light polypeptide gene enhancer in B-cell inhibitor, alpha, IKK IκB kinase, IL 1a interleukin 1a, JNK c-Jun N-terminal kinase, LBP 
lipopolysaccharide binding protein, LPS lipopolysaccharide, TLR toll-like receptor, MEK mitogen-activated protein kinase, NFκB nuclear factor κ-light-
chain-enhancer of activated B cells, Raf proto-oncogene serine/threonine-protein kinase, sCD14 soluble CD14, Src proto-oncogene tyrosine-protein 
kinase Src)
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verified in a preliminary study on four media, which are 
described in the literature as selective for this kind of 
pathogens [29, 30]. The results are presented in our pre-
vious manuscript [28].
Bacterial identification
Enzymatic typing was performed based on the enzy-
matic profiles obtained from the STREPTOtest 24 test 
(Lachema, Pliva) described in our previous manuscript 
[28].
Salivary β‑defensin‑2, HST‑5, and the determination 
of total protein concentration
The concentration of chosen antimicrobial peptides 
was determined by the competitive enzyme-linked 
immunosorbent assay (ELISA). About 50  μl of stand-
ard β-defensin-2, HST-5, or diluted saliva sample (saliva 
was diluted to 1:100 dilution by adding 4  μl of saliva to 
400  μl of phosphate buffered saline), 50  µl of enzyme 
(horseradish peroxidase)-labeled antigen, and 50  µl of 
anti-β-defensin-2, anti-HST-5 monoclonal antibodies 
(1:800) were added to the secondary antibody-coated 
96-well microliter plates and reacted at room tempera-
ture for 30  min. Then, the solution was decanted, and 
300  µl of washing solution was added to each well and 
also decanted; this procedure was repeated three times. 
Then, 100 µl of o-phenylenediamine (OPD) solution was 
added. After the enzyme reaction at room temperature 
for 15  min, the reaction was stopped by adding 100  µl 
of 0.25  mol  l−1 sulfuric acid. A standard curve was per-
formed with each assay using HBD-2 and HST-5 at 
Fig. 2 Signaling pathways in inducible expression of HST in epithelial cell. (AEP acquired enamel pellicle, LPS lipopolysaccharide, MAPK mitogen-
activated protein kinase, MMP matrix metalloproteinases, ROS reactive oxygen species) [24]. In the mechanism depending on protein kinases 
(MAPK), HST specifically assimilate with membrane receptors via a series of mechanisms inducing the production of reactive oxygen species (ROS) 
[25]. HST by a way of non-lytic outflow from cell lead to the release of ATP and inhibition of the main metabolic pathways (i.e. cellular respiration) 
[26]. Together with reactive oxygen species, HST release histamine from mast cells [27] and lead to DNA damage [28]. HST have a function of chelat-
ing transition metal ions (Cu2+ and Zn2+), which may be of importance for the protection of tooth enamel and antimicrobial protection
Table 1 Salivary HST-5 and  β-defensin-2 levels in  early 
childhood caries and controls
* t Test was used in the analysis
Healthy control 
(n = 41)
Early childhood  
caries (n = 41)
p*
Mean (ng/ml) SD Mean (ng/ml) SD
HST-5 15.29 1.16 50.75 2.11 0.0002
β-defensin-2 2.15 0.07 2.29 0.05 0.0417
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concentrations of 0.02, 0.05, 0.1, 0.5, 1, and 2 µg. Briefly, 
the wells of high-binding 96-well microliter plates (Corn-
ing Incorporated, Big Flats, NY, USA) were coated with 
50 µl of each β-defensin-2, HST-5 concentration, or TBS 
in the control wells. The optical density (OD) was meas-
ured at 450 nm [29], and the examined protein concentra-
tion in saliva was expressed as microgram per 1 ml saliva 
(µg ml)−1. Salivary protein level was measured by using a 
standard protein assay kit (BIO-RAD, Hercules, CA, USA) 
with bovine serum albumin as a standard. Three samples 
were collected from each patient on three different occa-
sions under same conditions. The experiments were per-
formed in duplicates in all three occasions.
Statistical analysis
The mean values were compared using the unpaired t test 
and one-way ANOVA with Scheffe’s multiple compari-
son test, respectively. Linear regression analysis was used 
to evaluate the simple correlation between examined 
protein level and Streptococcus mutans/Lactobacillus 
rhamnosus/Streptococcus sanguinis/Streptococcus mitis 
CFU counts. Multiple linear regression analysis was 
performed to determine the independent contribution 
of explanatory variables to bacterial strain CFU counts 
using age, sex, β-defensin-2, and HST-5 concentration.
Results
Salivary HST-5 and β-defensin-2 levels in patients with 
ECC (50.75 ± 2.11; 2.29 ± 0.05 ng/ml, respectively) were 
significantly increased compared with control (healthy 
subject) (15.29 ±  1.16; 2.15 ±  0.07  ng/ml, respectively) 
(p < 0.001, and 0.04, respectively; Table 1).
When the results were analyzed according to the car-
ies severity score, salivary HST-5 and β-defensin-2 lev-
els were significantly higher in severe group (cavitated 
lesion) which was considered to be ≥3 in ICDAS II codes 
(53.06 and 2.30  ng/ml, respectively) compared to the 
mild group (1–2 in ICDAS II codes) with the initial dem-
ineralization involvement (white spots/non-cavitated 
lesion) (44.53 and 2.22  ng/ml, respectively) (p  =  0.030 
and p = 0.021, respectively).
Cariogenic profile was the only bacterial species recov-
ered in severe and mild group of patients.
Noticeable is the high proportion of S. mutans and 
L. rhamnosus with severe group in relation to mild and 
control groups. Bacterial cultures demonstrated signifi-
cant differences in Streptococcus mutans/Lactobacillus 
rhamnosus/Streptococcus sanguinis/Streptococcus mitis pro-
files between the severe group (dentine damage), the mild 
group (white spots), and control group (p = 0.04, Fig. 3).
Alternatively, ELISA results demonstrated a sig-
nificant growth in HST-5 (p  =  0.03) and β-defensin-2 
(p = 0.04) concentrations in the saliva of the severe group 
compared with the mild group, where HST-5 levels in the 
mild population ranged between 40.11 and 45.23  ng/ml 
(average 42.55 ±  0.36 ng/ml) and in severe group (den-
tine damage) between 49.37 and 51.86  ng/ml (average 
50.55 ± 0.50 ng/ml) (Table 2).
Fig. 3 Cariogenic profile in early childhood caries between the 
severe, the mild, and control groups
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Discussion
Dental caries is an infectious disease and is one of the 
most common diseases among children and teenagers in 
the world [30]. Despite numerous studies on etiology and 
development of the disease, scientists still do not agree 
on some of its aspects. Until recently, S. mutans, which 
has the ability to form biofilm in the oral cavity, was con-
sidered to be the main etiological factor of caries [31, 
32]. The one which is currently prevailing is the opinion 
on complex bacterial component of caries etiology. This 
process, apart from S. mutans, involves several other key 
bacterial species, i.e.: S. sobrinus, Lactobacillus acidophi-
lus, and Actinomyces viscosus [33–37].
The objective of the study was to determine the lev-
els of HST-5, β-defensin-2 and to compare them with 
bacterial profiles depending on caries progression. The 
obtained results demonstrated significantly higher HST-5 
and β-defensin-2 levels in saliva of children with severe 
ECC compared to patients with the initial demineraliza-
tion involvement (white spots/non-cavitated lesion).
The obtained results are consistent with the results of 
Gornowicz et  al., who demonstrated increased level of 
HST-5 in group of children with severe caries, but higher 
concentrations were observed in children with severe 
form of the disease compared to patients with the initial 
demineralization involvement [38].
Increased activity of HST-5 was observed in wide pH 
range. However, in low pH (with presence of caries dental 
changes) protonation of histidine residues occurs, addi-
tionally increasing the antimicrobial force [18, 39]. Not 
only the primary form of HST-5 but also its synthetic 
equivalent, P-113 peptide, maintains their biological 
potential. Due to the proteolytic degradation of HST-5 
in the oral cavity, P-113 exhibits significantly greater 
effectiveness toward cariogenic strains of S. mutans. This 
peptide penetrates into the cellular cytoplasm without 
disturbing the cell membrane integrity and has a signifi-
cant affinity to microbial DNA [40–42].
Considering the relationship of β-defensin-2 (HBD-2) 
to caries, Ribeiro et al., Tao et al., and Dale et al. obtained 
the results that were inconsistent with the results 
presented in this study [43–45]. According to these 
authors, HBD-2 does not correlate with the occurrence 
of caries which is in contrast with HBD-1 and HNP-3 
(α-defensin-3).
Also, Phattarataratip and coworkers did not demon-
strate the relationship of HBD-2 with the symptoms of 
the disease; however, a trend in the increase of defensin 
level together with the increase of total content of bac-
teria from the mutans streptococci group was observed. 
Strains of S. mutans isolated from persons with car-
ies had greater resistance to β-defensin-2 compared to 
strains isolated from control group [46].
It is generally known that HBD-2 exhibits the greatest 
activity toward Gram-negative bacteria and to a lower 
level toward Gram-positive bacteria. Cariogenic spe-
cies, which are the most sensitive to their activity, are S. 
mutans and S. sobrinus [47], although HBD-2 are, com-
pared to other salivary proteins, for instance, cathelici-
din (LL37) significantly more specific toward S. mutans, 
which was corroborated by the results obtained in other 
studies [48].
This study demonstrated that the amount of specific 
salivary proteins of the host may influence colonization 
of each species of bacteria, including S. mutans and also 
that domination of strains considered to be more cari-
ogenic, such as S. mutans is closely linked to the level of 
caries advancement (severe and moderate caries) which 
is reflected in increased level of selected salivary proteins 
of the host, both HST-5 and β-defensin-2.
When searching for the relation between the levels of 
HST-5 and β-defensin-2 and the number of cariogenic 
species of bacteria, the occurrence of specific bacterial 
profiles depending on the levels of the determined pro-
teins was noticed. These data correlated with clinical data 
on caries severity. A recent study evaluating population 
of oral cavity microbes in children 3–12 years of age sug-
gests that teeth microflora is related to an entire ecosys-
tem of species of bacteria that it is made up of and not 
only a small portion related to a small number of selected, 
specific pathogenic species of bacteria, which together 
determine caries development [49, 50]. The results 
which were obtained from the group of children with 
mild caries often being described as white spots (Strep-
tococcus mutans/Lactobacillus rhamnosus/Streptococcus 
sanguinis/Streptococcus mitis 9  %–4  %–56  %–31  %) are 
consistent with results of Aas et  al. [51] and van Houte 
et  al., who demonstrated that 10  % of children and 
teenagers with caries (2–21 years of age) do not have S. 
mutans at all. The participation of other bacterial species 
in the development and progression of dental caries is 
suggested, such as Lactobacillus, Veillonella, Bifidobac-
terium, Propionibacterium, acidogenic species independ-
ent of Streptococcus mutans (i.e.: S. gordonii, S. oralis, S. 
Table 2 Salivary HST-5 and  β-defensin-2 levels in  severe 
and mild groups of patients
No correlation was observed between HST-5, β-defensin-2 levels, and age, 
gender, social habits, diets, medications or any other co-founding factors (not 
published results)
The severe group 
(n = 24)
The mild group  
(n = 17)
p*
Mean (ng/ml) SD Mean (ng/ml) SD
HST-5 50.55 0.50 42.55 0.36 0.03
β-defensin-2 2.22 0.19 1.74 0.21 0.04
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mitis, S. anginosus) [52], Actinomyces, and Atopobium, 
which was confirmed in this study. In the case of the 
group of the so-called white spots, the participation of 
S. mutans was higher compared to the control group 
(9  % white spot >2  % control), which was confirmed in 
the study by van Houte et al. in which S. mutans consti-
tuted 0.001 to 10 % [53]. Species of Streptococcus (apart 
from S. mutans) and Actinomyces are considered the 
main culprits of enamel damage. In the case of S. mutans 
and Lactobacillus absence, the initial demineralization of 
enamel may be induced by early colonizers (S. sanguinis, 
S. mitis, and S. oralis), which was also presented in this 
study, where Streptococcus sanguinis constituted 56 % in 
children of the white spot group.
In children from severe group participation of S. 
mutans amounted to 33 %, which is consistent with the 
results of Gross et al. [54] and Sampaio-Maia and Mon-
teiro-Silva [55] in which in dentine damage, the partici-
pation of S. mutans amounted to approximately 30 % of 
total microflora. S. mutans was not a dominant species in 
the advanced stage of caries, where Lactobacillus, Bifido-
bacterium, and Prevotella dominated. Virulence of popu-
lations of cariogenic bacteria correlates with the accepted 
phenotype for a given environment related to bacteria 
acidogenic potential which may induce changes of the 
environment leading to the development of dental caries.
Under physiological conditions, the oral cavity of chil-
dren compared to adult persons has higher percentage 
of bacteria belonging to phyla: Firmicutes (genera Strep-
tococcus, Veillonella, Lactobacillus, and Granulicatella) 
and Actinobacteria (genera Rothia and Actinomyces) 
and lower percentage of bacteria from phyla Bacteroi-
detes (genera Bacteroidales and Prevotella), Fusobac-
teria (genus Fusobacterium), Spirochaetes, and TM7 
strain [56]. Interestingly, percentage of cariogenic bacte-
ria increases with the age of children. This change con-
sists in a shift from populations of aerobic bacteria or 
facultative Gram-positive cocci to relatively anaerobic 
Gram-negative bacteria [50]. In this study, in the con-
trol group, non-pathogenic species dominated (Strepto-
coccus mutans/Lactobacillus rhamnosus/Streptococcus 
sanguinis/Streptococcus mitis 2 %–5 %–22 %–15 %–56 % 
other species), which confirms the hypothesis on envi-
ronment-dependent bacterial profile.
This study indicates great opportunities of using HST-5 
in combination with β-defensin-2 in dentistry. If the 
potential of antibacterial peptides is to be utilized as pro-
spective biomarkers of various diseases, including devel-
opment and progression of dental caries together with 
proper hygiene of the oral cavity, patient education and 
professional prevention measures, a new approach will 
be created, leading to improved prevention, diagnostics, 
and dental caries treatment.
Antimicrobial peptides, to which mentioned proteins 
belong, have numerous favorable characteristics such as 
wide range of activity, quick antibacterial effect, competi-
tiveness toward traditional antibiotics, thanks to which 
they are potential tools for the treatment of numerous 
humans and animal diseases caused by biological factors.
The results of the above-described study, in which 
we observed an increase in the level of histatin-5 and 
β-defensin-2 along with the severity of dental caries, 
prove that selected antimicrobial peptides may serve as a 
tool in the prevention and treatment of dental caries espe-
cially in children that are at risk of this disease. Further-
more, the overall demand for the use of natural substances 
cause the increased interesting in the use of antimicrobial 
peptides. Consequently, there are possibilities to develop 
new strategies to treat this disease. Antibacterial peptides 
are the alternatives to conventional antibiotic treatment. 
Many studies have been performed on hundreds of anti-
microbial peptides that can be used for a more targeted 
approach associated with selective control or elimination 
of strains causing tooth decay in children.
In addition, antimicrobial peptides properties are 
much safer for the youngest users. Our studies indi-
cate that antimicrobial peptides such as histatin-5 and 
β-defensin-2 should be further studied. Their potential 
use in oral therapy should be also discussed.
Conclusions
This study has shown that there is a relationship between 
the amount of salivary β-defensin-2 and Histatin-5 and 
caries advancement (severe and moderate caries). The 
occurrence of specific bacterial profiles depending on the 
levels of the determined proteins was noticed. The use 
of the saliva proteins concentration could have potential 
applications in the monitoring of oral diseases, such as 
caries and periodontal diseases.
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